Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A David Rodrigues

Showing results (21-30 of 132) with videos related to

Pageof 14
Sort By:
The AAPS Journal|June 21, 2019
Guidance for Rifampin and Midazolam Dosing Protocols To Study Intestinal and Hepatic Cytochrome P450 (CYP) 3A4 Induction and De-inductionAsha J Kapetas, Michael J Sorich, A David Rodrigues, et al.
Molecular Pharmaceutics|June 16, 2018
Quantification of Hepatic Organic Anion Transport Proteins OAT2 and OAT7 in Human Liver Tissue and Primary HepatocytesAnna Vildhede, Emi Kimoto, A David Rodrigues, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 6, 2007
Cytochrome P450 reaction-phenotyping: an industrial perspectiveHongjian Zhang, Carl D Davis, Michael W Sinz, et al.
Pharmaceutical Research|September 28, 2007
Projection of exposure and efficacious dose prior to first-in-human studies: how successful have we been?Christine Huang, Ming Zheng, Zheng Yang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 13, 2013
Assessment of vandetanib as an inhibitor of various human renal transporters: inhibition of multidrug and toxin extrusion as a possible mechanism leading to decreased cisplatin and creatinine clearanceHong Shen, Zheng Yang, Weiping Zhao, et al.
Bioanalysis|April 19, 2023
LC-MS/MS method for the quantitation of OCT1 biomarker isobutyrylcarnitine in human plasma with clinical sample analysisAmy Troop, Eugene Kadar, Emi Kimoto, et al.
Bioanalysis|February 20, 2024
Inception and development of a LC-MS/MS assay for the multiplexed quantitation of nine human drug transporter biomarkersEugene P Kadar, Christopher L Holliman, Manoli Vourvahis, et al.
Journal of Applied Toxicology : JAT|May 31, 2018
Species differences in bile acids II. Bile acid metabolismRhishikesh Thakare, Jawaher Abdullah Alamoudi, Nagsen Gautam, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 22, 2004
Cytochrome P450 2C8 (CYP2C8)-mediated hydroxylation of an endothelin ETA receptor antagonist in human liver microsomesBennett Ma, Raju Subramanian, Michael L Schrag, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 12, 2012
Impact of nonlinear midazolam pharmacokinetics on the magnitude of the midazolam-ketoconazole interaction in ratsRagini Vuppugalla, Yueping Zhang, Shu Chang, et al.
Pageof 14

Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
The AAPS Journal|June 21, 2019
Guidance for Rifampin and Midazolam Dosing Protocols To Study Intestinal and Hepatic Cytochrome P450 (CYP) 3A4 Induction and De-inductionAsha J Kapetas, Michael J Sorich, A David Rodrigues, et al.
Molecular Pharmaceutics|June 16, 2018
Quantification of Hepatic Organic Anion Transport Proteins OAT2 and OAT7 in Human Liver Tissue and Primary HepatocytesAnna Vildhede, Emi Kimoto, A David Rodrigues, et al.
Expert Opinion on Drug Metabolism & Toxicology|October 6, 2007
Cytochrome P450 reaction-phenotyping: an industrial perspectiveHongjian Zhang, Carl D Davis, Michael W Sinz, et al.
Pharmaceutical Research|September 28, 2007
Projection of exposure and efficacious dose prior to first-in-human studies: how successful have we been?Christine Huang, Ming Zheng, Zheng Yang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 13, 2013
Assessment of vandetanib as an inhibitor of various human renal transporters: inhibition of multidrug and toxin extrusion as a possible mechanism leading to decreased cisplatin and creatinine clearanceHong Shen, Zheng Yang, Weiping Zhao, et al.
Bioanalysis|April 19, 2023
LC-MS/MS method for the quantitation of OCT1 biomarker isobutyrylcarnitine in human plasma with clinical sample analysisAmy Troop, Eugene Kadar, Emi Kimoto, et al.
Bioanalysis|February 20, 2024
Inception and development of a LC-MS/MS assay for the multiplexed quantitation of nine human drug transporter biomarkersEugene P Kadar, Christopher L Holliman, Manoli Vourvahis, et al.
Journal of Applied Toxicology : JAT|May 31, 2018
Species differences in bile acids II. Bile acid metabolismRhishikesh Thakare, Jawaher Abdullah Alamoudi, Nagsen Gautam, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 22, 2004
Cytochrome P450 2C8 (CYP2C8)-mediated hydroxylation of an endothelin ETA receptor antagonist in human liver microsomesBennett Ma, Raju Subramanian, Michael L Schrag, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 12, 2012
Impact of nonlinear midazolam pharmacokinetics on the magnitude of the midazolam-ketoconazole interaction in ratsRagini Vuppugalla, Yueping Zhang, Shu Chang, et al.
Pageof 14